Skip to main content
Premium Trial:

Request an Annual Quote

Stupid Strong Awards City of Hope $125K for Gastric Cancer Liquid Biopsy Research

NEW YORK – The Stupid Strong Charitable Foundation has awarded Los Angeles-based City of Hope $125,000 to fund a Phase II prospective study to validate micro-RNA biomarkers used to detect early-stage gastric cancer in patients.

The team aims to eventually develop non-invasive, blood-based liquid biopsy assays to diagnose gastric cancer in its early stages.

Ajay Goel, project principal investigator, aims to expand his prior research on the use of circulating biomarkers to develop the assays. He will also leverage the funding to discover and validate biomarkers for peritoneal carcinomas in gastric cancer.

"This pilot funding is seminal in developing proof-of-concept data that could lead to early detection of gastric cancer as well as personalized treatment that could prevent cancer recurrence," Goel said in a statement. "This funding will also help us look for biomarkers that can inform doctors if some patients can be prescribed chemotherapy prior to gastric surgery because their abdominal and pelvic area have peritoneal tumors."

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.